Abramson Cancer Center of the University of Pennsylvania ( Site 0010) is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.
Abramson Cancer Center of the University of Pennsylvania ( Site 0010) has participated in 4 clinical trials with 2 currently active.
Therapeutic areas: Carcinoma, Non-Small-Cell Lung.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Abramson Cancer Center of the University of Pennsylvania ( Site 0010) has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Abramson Cancer Center of the University of Pennsylvania ( Site 0010) has 4 clinical trials on record, with 2 currently active. Their work covers Carcinoma, Non-Small-Cell Lung.
Abramson Cancer Center of the University of Pennsylvania ( Site 0010) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.